Erythropoietin Market

The global Erythropoietin (EPO) market was valued at US$ 9422.9 million in 2022 and is projected to reach US$ 13750 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The USA market for Global Erythropoietin (EPO) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global Erythropoietin (EPO) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global Erythropoietin (EPO) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, the kidney will produce and secrete erythropoietin to increase the production of red blood cells by targeting CFU-E, proerythroblast and basophilic erythroblast subsets in the differentiation. Erythropoietin has its primary effect on red blood cell progenitors and precursors (which are found in the bone marrow in humans) by promoting their survival through protecting these cells from apoptosis, or cell death.

In Erythropoietin Market , we definite one unit for 1ml, except Epoetin-alfa type, which one unit means 10000units/ml

Erythropoietin Market aims to provide a comprehensive presentation of the global market for Erythropoietin (EPO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythropoietin (EPO). Erythropoietin Market contains market size and forecasts of Erythropoietin (EPO) in global, including the following market information:

Global Erythropoietin (EPO) Market Revenue, 2018-2023, 2024-2030, ($ millions)

Global Erythropoietin (EPO) Market Sales, 2018-2023, 2024-2030, (Units)

Global top five Erythropoietin (EPO) companies in 2022 (%)

The major players in global Erythropoietin market include Amgen, Johnson & Johnson, etc. The top 2 players occupy about 60% shares of the global market. North America is the main market, and occupies over 65% of the global market. Epoetin-alfa is the main type, with a share about 80%. Kidney Disorders is the key application, which holds a share over 40%.

We surveyed the Erythropoietin (EPO) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

• Epoetin-alfa
• Darbepoetin-alfa
• Epoetin-beta
• Others

• Anemia
• Kidney Disorders
• Other

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

• Key companies Erythropoietin (EPO) revenues in global market, 2018-2023 (Estimated), ($ millions)
• Key companies Erythropoietin (EPO) revenues share in global market, 2022 (%)
• Key companies Erythropoietin (EPO) sales in global market, 2018-2023 (Estimated), (Units)
• Key companies Erythropoietin (EPO) sales share in global market, 2022 (%)

• Amgen
• Johnson & Johnson
• Roche
• Galenica
• Emcure
• Kyowa Hakko Kirin
• 3SBio
• Biocon
• LG Life Sciences

Outline of Major Chapters:

Chapter 1: Introduces the definition of Erythropoietin (EPO), market overview.

Chapter 2: Global Erythropoietin (EPO) market size in revenue and volume.

Chapter 3: Detailed analysis of Erythropoietin (EPO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Erythropoietin (EPO) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Erythropoietin (EPO) capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.